Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions

Oncogene

Volumn 26, Issue 4, 2007, Pages 543-553

  Oakes, S R ^a   Robertson, F G ^a   Kench, J G ^b   Gardiner Garden, M ^a   Wand, M P ^c   Green, J E ^d   Ormandy, C J ^a,e  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Western Sydney Area Health Service   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d Laboratory of Human Carcinogenesis   (United States)

^e ST VINCENT S HOSPITAL   (Australia)

Author keywords

C3(1) SV40T; Carcinogenesis; Mammary; Mouse; Prolactin receptor

Indexed keywords

PROLACTIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER GRADING; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENDOCRINE SYSTEM; FEMALE; GENE EXPRESSION; HORMONAL REGULATION; INVASIVE CARCINOMA; MALE; MORPHOLOGY; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; APOPTOSIS; BODY WEIGHT; CASPASE 3; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; MALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RECEPTORS, PROLACTIN;

ANIMALIA;

EID: 33846548174     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209838     Document Type: Article

References (52)

1. Attia MA, Weiss DW. (1966). Cancer Res 26: 1787-1800.
2. Binart N, Helloco C, Ormandy CJ, Barra J, Clement-Lacroix P, Baran N et al. (2000). Endocrinology 141: 2691-2697.
3. Bonneterre J, Mauriac L, Weber B, Roche H, Fargeot P, Tubiana-Hulin M et al. (1988). Eur J Cancer Clin Oncol 24: 1851-1853.
4. Bonneterre J, Peyrat JP, Beuscart R, Lefebvre J, Demaille A. (1987). Cancer Res 47: 4724-4728.
5. Bradbury JM, Edwards PA, Niemeyer CC, Dale TC. (1995). Dev Biol 170: 553-563.
6. Brisken C, Kaur S, Chavarria TE, Binart N, Sutherland RL, Weinberg RA et al. (1999). Dev Biol 210: 96-106.
7. Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ et al. (2000). Oncogene 19: 968-988.
8. Chen WY, Ramamoorthy P, Chen N, Sticca R, Wagner TE. (1999). Clin Cancer Res 5: 3583-3593.
9. Clement-Lacroix P, Ormandy C, Lepescheux L, Ammann P, Damotte D, Goffin V et al. (1999). Endocrinology 140: 96-105.
10. Clevenger CV, Chang WP, Ngo W, Pasha TL, Montone KT, Tomaszewski JE. (1995). Am J Pathol 146: 695-705.
11. Clevenger CV, Furth PA, Hankinson SE, Schuler LA. (2003). Endocrine Rev 24: 1-27.
12. Das R, Vonderhaar BK. (1997). J Mammary Gland Biol Neoplasia 2: 29-39.
13. DeOme KB, Faulkin LJJ, Bern HA, Blair PB. (1959). Cancer Res 19: 515-520.
14. Freemark M, Fleenor D, Driscoll P, Binart N, Kelly P. (2001). Endocrinology 142: 532-537.
15. Ginsburg E, Vonderhaar BK. (1995). Cancer Res 55: 2591-2595.
16. Goffin V, Bernichtein S, Touraine P, Kelly PA. (2005). Endocrine Rev 26: 400-422.
17. Goffin V, Kinet S, Ferrag F, Binart N, Martial JA, Kelly PA. (1996). J Biol Chem 271: 16573-16579.
18. Green JE, Shibata MA, Yoshidome K, Liu ML, Jorcyk C, Anver MR et al. (2000). Oncogene 19: 1020-1027.
19. Gutzman JH, Miller KK, Schuler LA. (2004). J Steroid Biochem Mol Biol 88: 69-77.
20. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D et al. (1998). J Natl Cancer Inst 90: 1292-1299.
21. Hankinson SE, Willett WC, Michaud DS, Manson JE, Colditz GA, Longcope C et al. (1999). J Natl Cancer Inst 91: 629-634.
22. Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ et al. (1997). EMBO J 16: 6926-6935.
23. Hutchinson JN, Muller WJ. (2000). Oncogene 19: 6130-6137.
24. Laird NM, Ware JH. (1982). Biometrics 38: 963-974.
25. Ling C, Hellgren G, Gebre-Medhin M, Dillner K, Wennbo H, Carlsson B et al. (2000). Endocrinology 141: 3564-3572.
26. Llovera M, Pichard C, Bernichtein S, Jeay S, Touraine P, Kelly PA et al. (2000). Oncogene 19: 4695-4705.
27. Manni A, Boucher AE, Demers LM, Harvey HA, Lipton A, Simmonds MA et al. (1989). Breast Cancer Res Treat 14: 289-298.
28. Maroulakou IG, Anver M, Garrett L, Green JE. (1994). Proc Natl Acad Sci USA 91: 11236-11240.
29. Mershon J, Sall W, Mitchner N, Ben-Jonathan N. (1995). Endocrinology 136: 3619-3623.
30. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. (2004). J Natl Cancer Inst 96: 1856-1865.
31. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. (1992). Cell 68: 869-877.
32. Naylor MJ, Lockefeer JA, Horseman ND, Ormandy CJ. (2003). Endocrine 20: 111-114.
33. Naylor MJ, Ormandy CJ. (2002). Dev Dyn 225: 100-105.
34. Ormandy CJ, Binart N, Kelly PA. (1997a). J Mammary Gland Biol Neoplasia 2: 355-364.
35. Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H et al. (1997b). Genes Dev 11: 167-178.
36. Ormandy CJ, Hall RE, Manning DL, Robertson JF, Blamey RW, Kelly PA et al. (1997c). J Clin Endocrinol Metab 82: 3692-3699.
37. Peyrat JP, Vennin P, Bonneterre J, Hecquet B, Vandewalle B, Kelly PA et al. (1984). Eur J Cancer Clin Oncol 20: 1363-1367.
38. Pinheiro J, Bates D, DebRoy S, Sarkar D. (2005). R package version 3: 1-65.
39. Reynolds C, Montone KT, Powell CM, Tomaszewski JE, Clevenger CV. (1997). Endocrinology 138: 5555-5560.
40. Robertson FG, Harris J, Naylor MJ, Oakes SR, Kindblom J, Dillner K et al. (2003). Endocrinology 144: 3196-3205.
41. Rose-Hellekant TA, Arendt LM, Schroeder MD, Gilchrist K, Sandgren EP, Schuler LA. (2003). Oncogene 22: 4664-4674.
42. Schroeder MD, Brockman JL, Walker AM, Schuler LA. (2003). Endocrinology 144: 5300-5307.
43. Schroeder MD, Symowicz J, Schuler LA. (2002). Mol Endocrinol 16: 45-57.
44. Shibata MA, Jorcyk CL, Liu ML, Yoshidome K, Gold LG, Green JE. (1998). Toxicol Pathol 26: 177-182.
45. Touraine P, Martini JF, Zafrani B, Durand JC, Labaille F, Malet C et al. (1998). J Clin Endocrinol Metab 83: 667-674.
46. Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE. (2004). Cancer Res 64: 6814-6819.
47. Vomachka AJ, Pratt SL, Lockefeer JA, Horseman ND. (2000). Oncogene 19: 1077-1084.
48. Vonderhaar BK. (1999). Endocrine-Related Cancer 6: 389-404.
49. Welsch CW, Louks G, Fox D, Brooks C. (1975). Br J Cancer 32: 427-431.
50. Welsch CW, Nagasawa H. (1977). Cancer Res 37: 951-963.
51. Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Tornell J. (1997). J Clin Invest 100: 2744-2751.
52. Wennbo H, Tornell J. (2000). Oncogene 19: 1072-1076.